Exploring Solutions for the Effective and Rapid Development of LAIs
Reserve Your Virtual Seat!
Use of long-acting injectables (LAIs) is rapidly growing across the pharmaceutical industry for the treatment of chronic conditions and infectious diseases, the delivery of hormonal contraceptives and antipsychotic drugs, and more. Experts in the field across the pharmaceutical, regulatory, and academic landscape need to come together now to collaborate, identify gaps, and define strategies to accelerate the development of this game-changing class of drug products.
Join us March 9-10 for the live workshop:
Patient-Centric Design of Long-Acting Injectable Drug Products.
Register Now!
This timely, 4-part workshop will discuss the current LAI drug product landscape and work toward actionable solutions, bringing together input from regulatory agencies, academia, and industry.
Topics include:
• Formulation and manufacturability challenges/opportunities for design and development of LAIs
• Current status and gaps in in-vivo models and mechanistic understanding for performance assessment
• Opportunities and challenges for LAI development from a regulatory perspective
• Focus on in-silico modeling challenges and ideas for implementation
Register for the entire 2-day workshop and save! Or purchase individual sessions.
AAPS members receive a discount on registration. Not a member? Join today and save as much as $195 when you register for the full workshop.
Bring four or more paid full conference attendees from the same company and receive a 15% discount per full conference registration. Email the AAPS Meetings Team to learn more.
Registrants have access to session slides as well as post-event recordings.
Partners: For information on opportunities that accompany this meeting, contact Mary Nugent, AAPS Account Manager.